Thursday, November 13, 2014

FDA's risk-based oversight of lab tests closes key gap


  1. The Hill (blog)-17 hours ago
    The increasing prevalence of laboratory-developed tests (LDTs) for conditions like cancer and other life-threatening diseases, which often do not undergo FDA ...

No comments: